This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novoheart International Limited. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Bernard Fermini: Innovator in Organoid Technology
Introduction
Bernard Fermini is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of organoid technology, particularly in the development of bioreactors for organoid culture and testing. His innovative work has the potential to advance medical research and therapeutic applications.
Latest Patents
Fermini holds a patent for "Devices comprising organoid chambers and uses thereof to culture, maintain, monitor or test organoids." This patent describes multi-layer bioreactors designed for growing, maintaining, stimulating, monitoring, and testing organoids and tissues derived from hollow organs. The bioreactors are instrumental in modeling disease processes, monitoring disease progression, and assessing biological effects such as therapeutic efficacy and organotoxicity. Additionally, the patent discloses systems for measuring various parameters of organoid chambers, including volume, pressure, contractility, pump function, and electrophysiology.
Career Highlights
Bernard Fermini is associated with Novoheart International Limited, where he continues to push the boundaries of organoid research. His work is pivotal in creating advanced bioreactor systems that can significantly impact the understanding of organ function and disease modeling.
Collaborations
Fermini collaborates with esteemed colleagues, including Eugene K Lee and David D Tran, who contribute to the innovative projects at Novoheart International Limited.
Conclusion
Bernard Fermini's contributions to organoid technology through his patent and work at Novoheart International Limited highlight his role as a leading inventor in this emerging field. His innovations are set to enhance the future of biomedical research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile